Edition:
United Kingdom

Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

35.91USD
19 Oct 2018
Change (% chg)

$0.46 (+1.30%)
Prev Close
$35.45
Open
$35.96
Day's High
$36.26
Day's Low
$35.67
Volume
504,636
Avg. Vol
217,780
52-wk High
$39.45
52-wk Low
$30.20

Chart for

About

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and... (more)

Overall

Beta: 1.13
Market Cap(Mil.): $7,880.51
Shares Outstanding(Mil.): 230.83
Dividend: 1.08
Yield (%): --

Financials

  QGEN.N Industry Sector
P/E (TTM): 104.06 85.41 33.64
EPS (TTM): 0.33 -- --
ROI: 1.87 0.21 14.27
ROE: 2.97 1.17 15.99

BRIEF-HTG Molecular Diagnostics Gets Notice From Qiagen Manchester

* HTG MOLECULAR DIAGNOSTICS SAYS RECEIVED NOTICE FROM QIAGEN MANCHESTER LTD THAT QIAGEN ENDED FIRST STATEMENT OF WORK, DATED JUNE 14, 2017 - SEC FILING Source text: (https://bit.ly/2rW1VKY) Further company coverage:

21 May 2018

BRIEF-Qiagen Reports Q1 Adjusted EPS $0.26

* QIAGEN NV SAYS Q1 REVENUE ROSE 12 PERCENT TO $343.6 MILLION VERSUS AVERAGE. F'CAST FOR $339 MILLION IN REUTERS POLL

02 May 2018

Qiagen beats expectations for Q1 sales and profit growth

May 2 Genetic testing specialist Qiagen NV beat expectations for quarterly sales and profit growth on Wednesday, buoyed by strong demand for its tuberculosis test and companion diagnostics, which match patients with the most effective drugs.

02 May 2018

Earnings vs. Estimates